Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 05, 2026 11:48 ET | Source: EnGeneIC

EnGeneIC Honored with 2026 Breakthrough in Glioblastoma Biotech Award at Northwell Foundation Lenox Hill Neurosurgery Brain Cancer Gala in New York

EnGeneIC Honored with 2026 Breakthrough in glioblastoma Biotech Award at Northwell Foundation Lenox Hill Neurosurgery Brain Cancer Gala in New York
June 04, 2026 02:30 ET | Source: ALK Abello

ALK will present data on real world-use of nasal adrenaline and key learnings from 20 years with SLIT-tablets at EAACI 2026

At the Annual Congress of the European Academy of Allergy and Clinical Immunology (EAACI) which will this year take part in Istanbul, Türkiye from 12 to 15 June 2026, the Danish pharmaceutical company...
June 01, 2026 07:00 ET | Source: Nouscom Srl

Nouscom Receives U.S. FDA Fast Track Designation for NOUS-209, a Novel Immunotherapy for the Prevention of Lynch Syndrome-Associated Cancers

Nouscom receives FDA Fast Track Designation for NOUS-209, advancing development of its cancer-prevention immunotherapy for Lynch Syndrome carriers.
May 28, 2026 09:04 ET | Source: MiNK Therapeutics

MiNK Therapeutics Announces First Patient Dosed in Randomized Phase 2 Trial of agenT-797 in Acute Lung Injury and Critical Illness

First patient dosed marks rapid transition from trial activation to active treatment in patients with acute lung injury from all cause pneumonia meeting Global ARDS criteriaLandmark advances a...
May 28, 2026 07:00 ET | Source: Treos Bio Corp.

TREOS Bio Appoints Sunjeet Sawhney as Chief Executive Officer

LONDON, May 28, 2026 (GLOBE NEWSWIRE) -- TREOS Bio, a clinical-stage biotechnology company developing next-generation off-the-shelf peptide cancer immunotherapies, supported by biomarker-guided...
May 26, 2026 08:00 ET | Source: Brain Cancer Canada

Brain Cancer Canada Invests $50,000 in Promising Immunotherapy Breakthrough Targeting One of the Most Aggressive Brain Tumours

TORONTO, May 26, 2026 (GLOBE NEWSWIRE) -- Brain Cancer Canada (BCC), Canada’s only 100% volunteer-driven charity dedicated exclusively to funding brain cancer research nationwide is proud to award...
May 21, 2026 08:00 ET | Source: Brain Cancer Canada

Brain Cancer Canada Awards The Dwayne Andrews Glioblastoma Research Grant to Tackle One of the Most Aggressive Brain Tumours and Unlock Immunotherapy Breakthroughs for Young Patients

TORONTO, May 21, 2026 (GLOBE NEWSWIRE) -- Brain Cancer Canada (BCC), the country’s only 100% volunteer-driven charity dedicated exclusively to funding brain cancer research nationwide, is proud to...
May 21, 2026 07:26 ET | Source: Research and Markets

Laryngeal Cancer Market Research Report 2026-2036, Competitive Analysis of Major Players - Merck & Co., Pfizer, Novartis, and AbbVie

Dublin, May 21, 2026 (GLOBE NEWSWIRE) -- The "Laryngeal Cancer Market - A Global and Regional Analysis: Focus on Treatment, Country, 2026-2036" report has been added to ResearchAndMarkets.com's...
May 19, 2026 06:10 ET | Source: Research and Markets

Pet Allergy Treatment Market Trends and Business Opportunities 2026-2035 by Drug Class, Pet Type, Route of Administration, Distribution Channel and Region

Dublin, May 19, 2026 (GLOBE NEWSWIRE) -- The "Pet Allergy Treatment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035" has been added to ResearchAndMarkets.com's...
May 18, 2026 00:00 ET | Source: NovalGen Ltd.

NovalGen Appoints Dr Laurent Fischer as Chair of the Board

NovalGen appoints Dr Laurent Fischer as Chair of the Board of Directors with immediate effect.